Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 5:30 pm Purchase |
2021-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Perceptive Advisors LLC | 2,927,565 9.900% |
1,350,084 (+85.58%) |
Filing History |
| 2022-02-14 5:30 pm Sale |
2021-12-31 | 13G | SCYNEXIS, Inc. SCYX |
Perceptive Advisors LLC | 0 0.000% |
-1,300,000 (Position Closed) |
Filing History |
| 2022-02-14 5:28 pm Unchanged |
2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Perceptive Advisors LLC | 1,296,416 6.300% |
0 (Unchanged) |
Filing History |
| 2022-02-14 5:20 pm Sale |
2021-12-31 | 13G | C4 Therapeutics, Inc. CCCC |
Perceptive Advisors LLC | 2,208,913 4.500% |
-949,653 (-30.07%) |
Filing History |
| 2022-02-14 5:18 pm Sale |
2021-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT |
Perceptive Advisors LLC | 1,959,125 3.000% |
-1,437,742 (-42.33%) |
Filing History |
| 2022-02-14 5:18 pm Sale |
2021-12-31 | 13G | Provention Bio, Inc. PRVB |
Perceptive Advisors LLC | 948,481 1.500% |
-2,684,542 (-73.89%) |
Filing History |
| 2022-02-14 5:15 pm Unchanged |
2021-12-31 | 13G | Research Alliance Corp. II RACB |
Perceptive Advisors LLC | 1,000,000 6.500% |
0 (Unchanged) |
Filing History |
| 2022-02-14 5:11 pm Sale |
2021-12-31 | 13G | Rain Enhancement Technologies Holdco Inc RAIN |
Perceptive Advisors LLC | 2,483,619 9.400% |
-53,400 (-2.10%) |
Filing History |
| 2022-02-14 5:05 pm Unchanged |
2021-12-31 | 13G | Forte Biosciences, Inc. FBRX |
Perceptive Advisors LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:57 pm Sale |
2021-12-31 | 13G | IsoPlexis Corporation ISO |
Perceptive Advisors LLC | 4,875,530 12.300% |
-31,342 (-0.64%) |
Filing History |
| 2022-02-14 4:50 pm Sale |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Perceptive Advisors LLC | 1,845,555 3.000% |
-1,648,052 (-47.17%) |
Filing History |
| 2022-02-14 4:48 pm Sale |
2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX |
Perceptive Advisors LLC | 3,172,785 8.100% |
-141,247 (-4.26%) |
Filing History |
| 2022-02-14 4:40 pm Purchase |
2021-12-31 | 13G | BELLUS Health Inc. BLU |
Perceptive Advisors LLC | 7,645,234 7.400% |
2,903,880 (+61.25%) |
Filing History |
| 2022-02-14 4:38 pm Purchase |
2021-12-31 | 13G | enVVeno Medical Corporation NVNO |
Perceptive Advisors LLC | 954,248 9.900% |
954,248 (New Position) |
Filing History |
| 2022-02-14 4:10 pm Unchanged |
2021-12-31 | 13G | Albireo Pharma, Inc. ALBO |
Perceptive Advisors LLC | 2,360,139 12.200% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:01 pm Sale |
2021-12-31 | 13G | Neptune Wellness Solutions Inc. NEPT |
Perceptive Advisors LLC | 7,183 6.000% |
-8,685 (-54.73%) |
Filing History |
| 2022-02-14 3:57 pm Purchase |
2021-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
Perceptive Advisors LLC | 10,647 17.500% |
2,687 (+33.76%) |
Filing History |
| 2022-02-14 3:54 pm Purchase |
2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Perceptive Advisors LLC | 3,610,412 13.100% |
200,000 (+5.86%) |
Filing History |
| 2022-02-14 3:50 pm Sale |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
Perceptive Advisors LLC | 3,449,915 5.400% |
-2,224,796 (-39.21%) |
Filing History |
| 2022-02-14 3:50 pm Unchanged |
2021-12-31 | 13G | Athenex, Inc. ATNX |
Perceptive Advisors LLC | 676,623 12.400% |
0 (Unchanged) |
Filing History |